Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $105M | $141M | $194M | $270M | $366M | $671M | $802M | $632M | $634M | $738M |
| Revenue growth | — | 35.1% | 37.4% | 39.3% | 35.5% | 83.1% | 19.5% | -21.1% | 0.3% | 16.4% |
| Operating income | $16.0M | $14.0M | $26.0M | $36.1M | $69.8M | $167M | $225M | $47.7M | -$35.1M | $55.2M |
| Operating margin | 15.3% | 9.9% | 13.4% | 13.4% | 19.1% | 24.9% | 28.0% | 7.5% | -5.5% | 7.5% |
| Net income | $11.7M | $28.4M | $16.6M | $21.4M | $59.9M | $128M | $186M | $35.6M | -$25.5M | $48.9M |
| Net margin | 11.2% | 20.1% | 8.6% | 7.9% | 16.4% | 19.1% | 23.2% | 5.6% | -4.0% | 6.6% |
| EPS (diluted) | $0.34 | $0.72 | $0.37 | $0.44 | $1.11 | $2.24 | $3.24 | $0.63 | -$0.46 | $0.86 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.52M | $17.5M | $32.8M | $67.2M | $62.6M | $119M | $172M | $114M | $175M | $117M |
| Capital expenditures | $4.33M | $5.45M | $10.6M | $18.5M | $22.5M | $67.1M | $84.8M | $36.2M | $25.7M | $23.5M |
| Free cash flow | $3.20M | $12.0M | $22.1M | $48.7M | $40.2M | $51.9M | $87.2M | $77.7M | $150M | $93.9M |
| Share buybacks | — | — | — | — | — | $0.00 | $0.00 | $14.4M | $0.00 | $0.00 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $122M | $174M | $194M | $528M | $717M | $604M | $523M | $751M | $757M | $566M |
| Total assets | $289M | $744M | $775M | $1.40B | $1.90B | $2.36B | $2.52B | $2.83B | $2.83B | $2.95B |
| Total liabilities | — | $152M | $159M | $340M | $374M | $608M | $614M | $866M | $857M | $844M |
| Long-term debt | — | — | — | — | — | — | — | — | $526M | $542M |
| Shareholders' equity | $169M | $592M | $616M | $1.06B | $1.53B | $1.75B | $1.91B | $1.96B | $1.97B | $2.11B |
| Retained earnings | -$59.9M | -$31.5M | -$677K | $5.84M | $65.8M | $194M | $397M | $433M | $407M | $456M |
| Shares (wtd avg diluted) | 34.1B | 39.1M | 45.5M | 49.2M | 53.9B | 57.3B | 57.5B | 56.4B | 55.9B | 56.6B |
Every figure is extracted from REPLIGEN CORP’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.